Double-Blind, Placebo-Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy
-
- TASSIARI C. A.
- Institute of Clinical Neurology, Bellaria Hospital
-
- MICHELUCCI R
- Institute of Clinical Neurology, Bellaria Hospital
-
- CHAUVEL P
- CHU Pontchaillou/Service Neurologique, Rennes and Hospital St. Anne
-
- CHODKIEWICZ J
- CHU Pontchaillou/Service Neurologique, Rennes and Hospital St. Anne
-
- SHORVON S
- National Hospital
-
- HENRIKSEN O
- National Center for Epilepsy
-
- DAM M
- University Clinic of Neurology, Hvidovre Hospital
-
- REIFE R
- The R.W. Johnson Pharmaceutical Research Institute
-
- PLEDGER G
- The R.W. Johnson Pharmaceutical Research Institute
-
- KARIM R
- The R.W. Johnson Pharmaceutical Research Institute
この論文をさがす
収録刊行物
-
- Epilepsia : journal of the International League against Epilepsy
-
Epilepsia : journal of the International League against Epilepsy 37 (8), 763-768, 1996-08-01
- Tweet
詳細情報
-
- CRID
- 1570009749820850944
-
- NII論文ID
- 10009401999
-
- NII書誌ID
- AA00180597
-
- ISSN
- 00139580
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles